A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Johnson & Johnson stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 605,477 shares of JNJ stock, worth $88.3 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
605,477
Previous 573,004 5.67%
Holding current value
$88.3 Million
Previous $83.8 Million 17.16%
% of portfolio
0.52%
Previous 0.48%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$145.48 - $167.38 $4.72 Million - $5.44 Million
32,473 Added 5.67%
605,477 $98.1 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $2.38 Million - $2.6 Million
16,486 Added 2.96%
573,004 $83.8 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $86.4 Million - $90.6 Million
556,518 New
556,518 $88 Billion
Q4 2023

Aug 14, 2024

BUY
$145.6 - $158.88 $1.37 Million - $1.49 Million
9,387 Added 2.2%
435,805 $68.3 Billion
Q3 2023

Aug 14, 2024

SELL
$155.75 - $174.48 $6.27 Million - $7.02 Million
-40,230 Reduced 8.62%
426,418 $66.4 Billion
Q2 2023

Aug 14, 2024

BUY
$154.35 - $166.11 $12 Million - $12.9 Million
77,621 Added 19.95%
466,648 $77.2 Billion
Q1 2023

Aug 14, 2024

BUY
$151.05 - $180.26 $983,788 - $1.17 Million
6,513 Added 1.7%
389,027 $60.3 Billion
Q4 2022

Aug 14, 2024

BUY
$160.2 - $179.79 $2.13 Million - $2.39 Million
13,317 Added 3.61%
382,514 $67.6 Billion
Q3 2022

Aug 14, 2024

BUY
$161.33 - $179.52 $924,743 - $1.03 Million
5,732 Added 1.58%
369,197 $60.3 Billion
Q2 2022

Aug 14, 2024

SELL
$168.19 - $186.01 $2.32 Million - $2.57 Million
-13,817 Reduced 3.66%
363,465 $64.5 Billion
Q1 2022

Aug 14, 2024

SELL
$158.14 - $179.59 $31 Million - $35.1 Million
-195,722 Reduced 34.16%
377,282 $66.9 Billion
Q4 2021

Aug 30, 2024

SELL
$155.93 - $173.01 $1.85 Million - $2.05 Million
-11,857 Reduced 3.0%
383,682 $65.6 Billion
Q3 2021

Aug 30, 2024

BUY
$161.5 - $179.47 $5.75 Million - $6.39 Million
35,584 Added 9.89%
395,539 $63.9 Billion
Q2 2021

Aug 30, 2024

SELL
$159.48 - $171.07 $34 Million - $36.4 Million
-213,049 Reduced 37.18%
359,955 $59.3 Billion
Q1 2021

Aug 30, 2024

BUY
$153.07 - $170.48 $565,899 - $630,264
3,697 Added 1.06%
352,998 $58 Billion
Q4 2020

Aug 30, 2024

BUY
$137.11 - $157.38 $6.63 Million - $7.61 Million
48,331 Added 16.06%
349,301 $55 Billion
Q3 2020

Aug 30, 2024

SELL
$140.38 - $153.83 $1.31 Million - $1.43 Million
-9,302 Reduced 3.0%
300,970 $44.8 Billion
Q2 2020

Aug 30, 2024

BUY
$128.81 - $155.51 $662,856 - $800,254
5,146 Added 1.69%
310,272 $43.6 Billion
Q1 2020

Aug 30, 2024

SELL
$111.14 - $153.99 $2.03 Million - $2.81 Million
-18,243 Reduced 5.64%
305,126 $40 Billion
Q4 2019

Aug 30, 2024

SELL
$127.5 - $146.44 $871,080 - $1 Million
-6,832 Reduced 2.07%
323,369 $47.2 Billion
Q3 2019

Aug 30, 2024

SELL
$126.95 - $142.14 $1.51 Million - $1.7 Million
-11,931 Reduced 3.49%
330,201 $42.7 Billion
Q2 2019

Aug 30, 2024

SELL
$131.15 - $144.24 $10.6 Million - $11.6 Million
-80,510 Reduced 19.05%
342,132 $47.7 Billion
Q1 2019

Aug 30, 2024

SELL
$125.72 - $139.79 $3 Million - $3.34 Million
-23,901 Reduced 5.35%
422,642 $59.1 Billion
Q4 2018

Aug 30, 2024

SELL
$122.84 - $147.84 $15.5 Million - $18.7 Million
-126,461 Reduced 22.07%
446,543 $57.6 Billion
Q3 2018

Aug 30, 2024

BUY
$121.58 - $142.88 $495,681 - $582,521
4,077 Added 0.89%
462,018 $63.8 Billion
Q2 2018

Aug 30, 2024

BUY
$119.4 - $131.76 $5.75 Million - $6.34 Million
48,120 Added 11.74%
457,941 $55.6 Billion
Q1 2018

Aug 30, 2024

BUY
$125.1 - $148.14 $2.13 Million - $2.53 Million
17,064 Added 4.34%
409,821 $52.5 Billion
Q4 2017

Aug 30, 2024

BUY
$131.22 - $143.62 $204,834 - $224,190
1,561 Added 0.4%
392,757 $54.9 Billion
Q3 2017

Aug 30, 2024

BUY
$129.47 - $135.38 $314,223 - $328,567
2,427 Added 0.62%
391,196 $50.9 Billion
Q2 2017

Aug 30, 2024

SELL
N/A
-184,235
388,769 $51.4 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.